Literature DB >> 26453918

Macrophage migration inhibitory factor (MIF) is rendered enzymatically inactive by myeloperoxidase-derived oxidants but retains its immunomodulatory function.

Nina Dickerhof1, Lisa Schindler2, Jürgen Bernhagen2, Anthony J Kettle3, Mark B Hampton3.   

Abstract

Macrophage migration inhibitory factor (MIF) is an important player in the regulation of the inflammatory response. Elevated plasma MIF is found in sepsis, arthritis, cystic fibrosis and atherosclerosis. Immunomodulatory activities of MIF include the ability to promote survival and recruitment of inflammatory cells and to amplify pro-inflammatory cytokine production. MIF has an unusual nucleophilic N-terminal proline with catalytic tautomerase activity. It remains unclear whether tautomerase activity is required for MIF function, but small molecules that inhibit tautomerase activity also inhibit the pro-inflammatory activities of MIF. A prominent feature of the acute inflammatory response is neutrophil activation and production of reactive oxygen species, including myeloperoxidase (MPO)-derived hypochlorous acid and hypothiocyanous acid. We hypothesized that MPO-derived oxidants would oxidize the N-terminal proline of MIF and alter its biological activity. MIF was exposed to hypochlorous acid and hypothiocyanous acid and the oxidative modifications on MIF were examined by LC-MS/MS. Imine formation and carbamylation was observed on the N-terminal proline in response to MPO-dependent generation of hypochlorous and hypothiocyanous acid, respectively. These modifications led to a complete loss of tautomerase activity. However, modified MIF still increased CXCL-8/IL-8 production by peripheral blood mononuclear cells (PBMCs) and blocked neutrophil apoptosis, indicating that tautomerase activity is not essential for these biological functions. Pre-treatment of MIF with hypochlorous acid protected the protein from covalent modification by the MIF inhibitor 4-iodo-6-phenylpyrimidine (4-IPP). Therefore, oxidant generation at inflammatory sites may protect MIF from inactivation by more disruptive electrophiles, including drugs designed to target the tautomerase activity of MIF.
Copyright © 2015 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Apoptosis; Carbamylation; Cytokine; D-dopachrome tautomerase (D-DT, MIF-2); Hypochlorous acid; Inflammation; Macrophage migration inhibitory factor (MIF); Myeloperoxidase (MPO); Neutrophil

Mesh:

Substances:

Year:  2015        PMID: 26453918     DOI: 10.1016/j.freeradbiomed.2015.09.009

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  7 in total

1.  Identification of Iguratimod as an Inhibitor of Macrophage Migration Inhibitory Factor (MIF) with Steroid-sparing Potential.

Authors:  Joshua Bloom; Christine Metz; Saisha Nalawade; Julian Casabar; Kai Fan Cheng; Mingzhu He; Barbara Sherry; Thomas Coleman; Thomas Forsthuber; Yousef Al-Abed
Journal:  J Biol Chem       Date:  2016-10-28       Impact factor: 5.157

2.  Advances and Insights for Small Molecule Inhibition of Macrophage Migration Inhibitory Factor.

Authors:  Vinay Trivedi-Parmar; William L Jorgensen
Journal:  J Med Chem       Date:  2018-06-04       Impact factor: 7.446

3.  Macrophage Migration Inhibitory Factor Regulates U1 Small Nuclear RNP Immune Complex-Mediated Activation of the NLRP3 Inflammasome.

Authors:  Min Sun Shin; Youna Kang; Elizabeth R Wahl; Hong-Jai Park; Rossitza Lazova; Lin Leng; Mark Mamula; Smita Krishnaswamy; Richard Bucala; Insoo Kang
Journal:  Arthritis Rheumatol       Date:  2018-12-04       Impact factor: 10.995

Review 4.  The Multitasking Potential of Alarmins and Atypical Chemokines.

Authors:  Aphrodite Kapurniotu; Ozgun Gokce; Jürgen Bernhagen
Journal:  Front Med (Lausanne)       Date:  2019-01-23

Review 5.  OxMIF: a druggable isoform of macrophage migration inhibitory factor in cancer and inflammatory diseases.

Authors:  Michael Thiele; Seamas C Donnelly; Robert A Mitchell
Journal:  J Immunother Cancer       Date:  2022-09       Impact factor: 12.469

6.  Macrophage Migration Inhibitory Factor protects cancer cells from immunogenic cell death and impairs anti-tumor immune responses.

Authors:  Kristen N Balogh; Dennis J Templeton; Janet V Cross
Journal:  PLoS One       Date:  2018-06-04       Impact factor: 3.240

Review 7.  Post-translational regulation of macrophage migration inhibitory factor: Basis for functional fine-tuning.

Authors:  Lisa Schindler; Nina Dickerhof; Mark B Hampton; Jürgen Bernhagen
Journal:  Redox Biol       Date:  2017-12-06       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.